HAND1 and metabolic dysfunction-associated steatohepatitis: WD mice exhibited a pattern of steatosis, inflammation and fibrosis that resembles human NASH, whereas, WD mice treated with HXT + VitE showed a marked decrease of both steatosis and fibrosis (Figure 4A,B).